Have a feature idea you'd love to see implemented?
Let us know!
ATAI ATAI Life Sciences NV
Price (delayed)
$1.14
Market cap
$191.29M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.36
Enterprise value
$191.59M
Highlights
The company's gross profit rose by 39% YoY and by 36% QoQ
ATAI Life Sciences's revenue has increased by 39% YoY and by 36% QoQ
The net income has plunged by 72% from the previous quarter but it has soared by 60% YoY
ATAI's EPS has dropped by 71% since the previous quarter but it has soared by 61% year-on-year
ATAI's quick ratio has dropped by 51% year-on-year and by 14% since the previous quarter
The equity has declined by 25% since the previous quarter and by 21% year-on-year
Key stats
What are the main financial stats of ATAI
Market
Valuations
Earnings
Shares outstanding
167.8M
Market cap
$191.29M
Enterprise value
$191.59M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.14
Price to sales (P/S)
483.71
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
506.85
Revenue
$378,000
EBIT
-$54.63M
EBITDA
-$53.76M
Free cash flow
-$79.22M
Per share
Balance sheet
Liquidity
EPS
-$0.36
Free cash flow per share
-$0.49
Book value per share
$1
Revenue per share
$0
TBVPS
$1.35
Total assets
$215.78M
Total liabilities
$47.25M
Debt
$19.63M
Equity
$167.89M
Working capital
$100.26M
Debt to equity
0.12
Current ratio
6.68
Quick ratio
6.42
Net debt/EBITDA
-0.01
Margins
Efficiency
Dividend
EBITDA margin
-14,221.2%
Gross margin
100%
Net margin
-15,363.2%
Operating margin
-29,155.8%
Return on assets
-21.4%
Return on equity
-25.8%
Return on invested capital
-23.5%
Return on capital employed
-27.6%
Return on sales
-14,451.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ATAI stock price
How has the ATAI Life Sciences stock price performed over time
Intraday
-5.79%
1 week
-5%
1 month
-3.39%
1 year
-7.32%
YTD
-19.15%
QTD
-1.72%
Financial performance
How have ATAI Life Sciences's revenue and profit performed over time
Revenue
$378,000
Gross profit
$378,000
Operating income
-$110.21M
Net income
-$58.07M
Gross margin
100%
Net margin
-15,363.2%
The net income has plunged by 72% from the previous quarter but it has soared by 60% YoY
The net margin has surged by 71% year-on-year but it has declined by 26% since the previous quarter
ATAI Life Sciences's operating margin has increased by 44% YoY and by 31% from the previous quarter
The company's gross profit rose by 39% YoY and by 36% QoQ
Growth
What is ATAI Life Sciences's growth rate over time
Valuation
What is ATAI Life Sciences stock price valuation
P/E
N/A
P/B
1.14
P/S
483.71
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
506.85
ATAI's EPS has dropped by 71% since the previous quarter but it has soared by 61% year-on-year
The equity has declined by 25% since the previous quarter and by 21% year-on-year
The P/B is 3.6% more than the last 4 quarters average of 1.1
ATAI Life Sciences's revenue has increased by 39% YoY and by 36% QoQ
ATAI's P/S is 36% below its last 4 quarters average of 752.3
Efficiency
How efficient is ATAI Life Sciences business performance
The company's return on equity has shrunk by 80% QoQ but it has surged by 56% YoY
ATAI's ROA has dropped by 78% since the previous quarter but it has soared by 56% year-on-year
The company's return on invested capital has surged by 78% YoY but it has shrunk by 64% QoQ
ATAI's ROS has soared by 71% year-on-year but it is down by 32% since the previous quarter
Dividends
What is ATAI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ATAI.
Financial health
How did ATAI Life Sciences financials performed over time
The current ratio has plunged by 51% YoY and by 15% from the previous quarter
ATAI's quick ratio has dropped by 51% year-on-year and by 14% since the previous quarter
The debt is 88% smaller than the equity
The company's debt to equity has surged by 50% YoY and by 33% QoQ
The equity has declined by 25% since the previous quarter and by 21% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.